Search research articles
Contact Us
Filters
Showing results (541-550 of 740) with videos related to
Page
of 74
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]
Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
J Nemunaitis, F Khuri, I Ganly, et al.
Antibiotics (Basel, Switzerland)
|
August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.
Annals of Clinical Microbiology and Antimicrobials
|
June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae
Violet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
American Journal of Epidemiology
|
February 19, 2005
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms
Jessina C McGregor, Peter W Kim, Eli N Perencevich, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant <i>Klebsiella pneumoniae</i> isolates with diverse phenotypic and genotypic resistance mechanisms
Ramya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.
Infection Control and Hospital Epidemiology
|
July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests
Dror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
American Journal of Infection Control
|
May 3, 2015
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime
Teena Chopra, Dror Marchaim, Paul C Johnson, et al.
Experimental Gerontology
|
July 28, 2009
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Dominick G A Burton, Peter J Giles, Angela N P Sheerin, et al.
Infection Control and Hospital Epidemiology
|
June 14, 2011
A practical method for surveillance of novel H1N1 influenza using automated hospital data
Teena Chopra, Juliann Binienda, Mazin Mohammed, et al.
Page
of 74
Search research articles
Search
Showing results (541-550 of 740) with videos related to
Sort By:
Page
of 74
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]
Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer
J Nemunaitis, F Khuri, I Ganly, et al.
Antibiotics (Basel, Switzerland)
|
August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.
Annals of Clinical Microbiology and Antimicrobials
|
June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae
Violet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
American Journal of Epidemiology
|
February 19, 2005
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms
Jessina C McGregor, Peter W Kim, Eli N Perencevich, et al.
Antimicrobial Agents and Chemotherapy
|
December 19, 2025
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant <i>Klebsiella pneumoniae</i> isolates with diverse phenotypic and genotypic resistance mechanisms
Ramya Mahadevan, Estefany Garcia, Rajnikant Sharma, et al.
Infection Control and Hospital Epidemiology
|
July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests
Dror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
American Journal of Infection Control
|
May 3, 2015
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime
Teena Chopra, Dror Marchaim, Paul C Johnson, et al.
Experimental Gerontology
|
July 28, 2009
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Dominick G A Burton, Peter J Giles, Angela N P Sheerin, et al.
Infection Control and Hospital Epidemiology
|
June 14, 2011
A practical method for surveillance of novel H1N1 influenza using automated hospital data
Teena Chopra, Juliann Binienda, Mazin Mohammed, et al.
Page
of 74